CSIMarket Company Name, Ticker, Customers, else..
 
Adaptive Biotechnologies Corporation  (NASDAQ: ADPT)
 

Adaptive Biotechnologies's Suppliers Performance

ADPT's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ADPT Costs vs Sales of Suppliers Growth Adaptive Biotechnologies recorded an increase in cost of sales by 12.03 % year on year, sequentially cost of sales grew by 7.79 % in Q2.

• More on ADPT Suppliers



Adaptive Biotechnologies recorded increase in cost of sales by 12.03 % year on year, sequentially cost of sales grew by 7.79 % in Q2.

• More on ADPT Suppliers




Adaptive Biotechnologies's Comment on Supply Chain


The company depends on suppliers, including single-source suppliers, for laboratory equipment and materials. To mitigate concentration risk, it maintains surplus stock to provide time for sourcing alternative suppliers if necessary. One key supplier is Illumina, Inc., which supplies the Illumina NextSeq and NovaSeq X Plus systems along with reagents specifically designed for use with these sequencers. Replacing these reagents would necessitate acquiring and validating new sequencers and assays, potentially resulting in delays and increased costs.

Adaptive Biotechnologies's Comment on Supply Chain


The company depends on suppliers, including single-source suppliers, for laboratory equipment and materials. To mitigate concentration risk, it maintains surplus stock to provide time for sourcing alternative suppliers if necessary. One key supplier is Illumina, Inc., which supplies the Illumina NextSeq and NovaSeq X Plus systems along with reagents specifically designed for use with these sequencers. Replacing these reagents would necessitate acquiring and validating new sequencers and assays, potentially resulting in delays and increased costs.







ADPT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Adaptive Biotechnologies Corporation 4,453.57 308.08 -63.99 624
SUBTOTAL 0.00 0.00 0.00 -


Sources: Adaptive Biotechnologies Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Adaptive Biotechnologies Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.